Humana (NYSE:HUM) Trading 8.6% Higher – Here’s What Happened

Humana Inc. (NYSE:HUM)’s share price rose 8.6% on Monday . The stock traded as high as $331.87 and last traded at $331.5560. Approximately 254,686 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 1,920,737 shares. The stock had previously closed at $305.42.

Wall Street Analyst Weigh In

HUM has been the subject of several recent research reports. Morgan Stanley boosted their price target on shares of Humana from $146.00 to $217.00 and gave the stock an “underweight” rating in a research note on Friday, May 15th. Evercore upped their price objective on shares of Humana from $195.00 to $250.00 in a research note on Thursday, April 30th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research note on Tuesday, April 21st. Cantor Fitzgerald initiated coverage on shares of Humana in a research note on Wednesday, May 20th. They set an “overweight” rating for the company. Finally, Wolfe Research downgraded shares of Humana from a “strong-buy” rating to a “peer perform” rating in a research note on Wednesday, May 20th. Nine research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $272.65.

Humana Price Performance

The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The firm’s 50-day moving average is $231.96 and its 200-day moving average is $228.98. The company has a market cap of $39.64 billion, a PE ratio of 35.34, a PEG ratio of 2.21 and a beta of 0.76.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter in the previous year, the company earned $11.58 earnings per share. Humana’s quarterly revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts anticipate that Humana Inc. will post 9.01 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.1%. Humana’s payout ratio is currently 37.86%.

Hedge Funds Weigh In On Humana

Hedge funds and other institutional investors have recently modified their holdings of the stock. Montag A & Associates Inc. increased its position in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC grew its holdings in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the period. Fideuram Asset Management Ireland dac purchased a new stake in Humana in the fourth quarter worth about $27,000. Reflection Asset Management purchased a new stake in Humana in the fourth quarter worth about $29,000. Finally, Rosenberg Matthew Hamilton grew its holdings in Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.